Abstract: The present invention provides HEH4 polypeptides and nucleic acid molecules encoding the same. The invention also provides selective binding agents, vectors, host cells, and methods for producing HEH4 polypeptides. The invention further provides pharmaceutical compositions and methods for the diagnosis, treatment, amelioration, and/or prevention of diseases, disorders, and conditions associated with HEH4 polypeptides.

Abstract: A soft lithium-titanium zinc ferrite is provided which has a resistivity of at least 10.sup.7 ohm-cm measured at 20.degree. C. and 100 volts, prepared from a mixture of oxides and/or carbonates in proportions, calculated as oxides, satisfying the formulaLi.sub.a Ti.sub.t Zn.sub.z Mn.sub.m Fe.sub.b O.sub.4whereina=0.5 (1+t-z)b=0.5 (5-3t-z-2m-5.epsilon.)0.ltoreq.t.ltoreq.0.080.50.ltoreq.z.ltoreq.0.600.005.ltoreq.m.ltoreq.0.0350.02.ltoreq..epsilon..ltoreq.0.06and .beta. from 0.0015 to 0.05 molar equivalent of Bi, wherein the Bi is present in the starting mixture or is added after calcining. A process for producing these ferrites is provided, together with magnetic deflectors incorporating them.

Abstract: A soft ferrite having an initial permeability of around 1000, which can be operated at frequencies of less than 100 Kc/s and which have a resistivity of the order of 1 megohm-cm. The starting point of the manufacturing process is a mixture of the formula:0.25 (1+t-z) Li.sub.2 CO.sub.3 ; z ZnO; t TiO.sub.2 ; 0.25 (5-3t-z-5.epsilon.)Fe.sub.2 O.sub.3where:0.5.ltoreq.z.ltoreq.0.650.05.ltoreq.t.ltoreq.0.200.06.ltoreq..epsilon..ltoreq.0.09The mixture furthermore contains traces of MnCO.sub.3 and Bi.sub.2 O.sub.3. The mixture is crushed, calcined in an air atmosphere at 800.degree. C. and then sintered in an oxygen atmosphere at a temperature between 950.degree. and 1050.degree. C.